NEW HAVEN – JDRF Greater New Haven will hold its 13th annual Dream Gala on April 28 at the Omni New Haven Hotel at Yale.
"The evening, themed Past, Present, and Future, will include a cocktail reception, lively entertainment, and legendary live and silent auctions," according to a statement. "The 2012 Dream Gala will honor Albert Subbloie, President, CEO and Founder of Tangoe."
"Tangoe is the leading global provider of Communications Lifecycle Management (CLM) software and related services to a wide range of global enterprises. Founded in 2000, Tangoe currently supports more than 500 active clients, many of them large multinational corporations," the statement said.
Headquartered in Orange, Tangoe has nine operation centers around the globe, including international offices in Amsterdam, Netherlands and Kunshan, China, the statement said. JDRF is recognizing Subbloie "for his long-standing commitment to the Foundation's mission of finding a cure for diabetes and its complications."
The event will include musical talent, a nd "inspirational speakers" from the JDRF community. "The live and silent auctions will offer items ranging from luxurious vacation trips to autographed sports memorabilia to striking jewelry and clothing," the statement said.
The evening will highlight JDRF's signature Fund-A-Cure program, during which 100 percent tax-deductible donations may be made to research, the statement said.
"In 2011, the Dream Gala raised over $260,000 for diabetes research. JDRF hopes to continue its success this year through corporate sponsorships, donations, auction activity, ads and ticket sales."
Visit www.jdrfgnh.org for more information about the 13th Annual Dream Gala. Questions may be directed to the local JDRF Chapter at (203) 248-1880 or by email at greaternewhaven@jdrf.org.
About JDRF
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of every person affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of every person affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.
Since its founding in 1970, JDRF has awarded more than $1.6 billion to diabetes research. Past JDRF efforts have helped to significantly advance the care of people with this disease, and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered. More than 80 percent of JDRF's expenditures directly support research and research-related education.
Editor's note: All information in this post was contributed. (Pretty good job they did, eh?)
No comments:
Post a Comment